Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-24-008977

SVP, Chief Legal Officer gave up 18,030 shares (to pay taxes)

  • SVP, Chief Legal Officer acquired 60,871 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Daly Jason B. SVP, Chief Legal Officer 2024-03-03 Option exercise +22,645 37,126 D
Daly Jason B. SVP, Chief Legal Officer 2024-03-03 Shares withheld for taxes −7,166 $5.47 $39,198 29,960 D
Daly Jason B. SVP, Chief Legal Officer 2024-03-03 Option exercise +38,226 68,186 D
Daly Jason B. SVP, Chief Legal Officer 2024-03-03 Shares withheld for taxes −10,864 $5.47 $59,426 57,322 D
Derivatives
Daly Jason B. SVP, Chief Legal Officer 2024-03-03 Option exercise · Restricted Stock Units −22,645 45,290 D
Daly Jason B. SVP, Chief Legal Officer 2024-03-03 Option exercise · Restricted Stock Units −38,226 114,679 D
Daly Jason B. SVP, Chief Legal Officer 2024-03-04 Grant or award · Restricted Stock Units +143,519 143,519 D
Daly Jason B. SVP, Chief Legal Officer 2024-03-04 Grant or award · Performance-Based Restricted Stock Units +287,038 287,038 D
Loading xslF345X05/wk-form4_1709675630.xml…